本文へ移動
cccskills
無料GitHub で公開

endo-rtcgm-suggest-short-term-intermittent-t2dm

Suggests short-term, intermittent real-time CGM use in adult patients with type 2 diabetes not on prandial insulin who have A1C ≥7% and are willing and able to use the device. Triggered by phrases such as “T2DM basal-only, A1C ≥7%, consider intermittent CGM” or “Short-term CGM for non-prandial T2DM with elevated A1C”.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.9 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Suggest short-term intermittent RT-CGM for T2DM not on prandial insulin

STEP 1 — Gather Information

Confirm type 2 diabetes diagnosis, verify insulin regimen is basal-only (no prandial insulin), obtain latest A1C, assess patient willingness and ability to perform fingerstick calibrations and wear CGM sensor, and screen for contraindications (e.g., inability to afford, skin adhesive allergy, cognitive impairment, pregnancy without obstetric approval).

STEP 2 — Rule In / Rule Out

If the patient is an adult with T2DM not receiving prandial insulin → proceed to next step; otherwise, do not suggest intermittent RT-CGM (rule out).

STEP 3 — Classify or Stratify

If A1C is ≥7% and the patient is willing and able to use the device → classify as a candidate for short-term intermittent RT-CGM; otherwise, consider alternative approaches or reassess barriers.

STEP 4 — Decide

Prescribe a short-term intermittent RT-CGM regimen (e.g., 2 weeks of sensor use followed by 1 week off, repeated for 12 weeks), provide device-specific education and training (including calibration, trend interpretation, and alarm settings), schedule follow‑up visits to review CGM data and A1C, and adjust basal insulin or lifestyle recommendations based on observed glucose patterns.

Clinical Guardrails / Mimics / Pitfalls

Do not use in patients on prandial insulin; do not replace SMBG calibration with CGM alone; avoid in patients with severe hypoglycemia unawareness without supervision; do not use as a substitute for structured diabetes education; ensure patient understands sensor limitations (e.g., lag, need for confirmatory fingersticks); not indicated for pregnancy unless specifically advised; do not prescribe if patient unwilling or unable to perform required calibrations or afford supplies.

Concrete Clinical Example

A 58‑year‑old man with T2DM on basal insulin glargine only, A1C 8.2%, expresses willingness to wear a sensor and perform twice‑daily fingersticks, has no hypoglycemia unawareness, and can afford supplies. Prescribe intermittent RT‑CGM (2 weeks on/1 week off) for 12 weeks, provide education, review data at 4‑week intervals, and consider continuing if A1C drops ≥0.5% or time in range improves.

Source: Real-time continuous glucose monitors in adult outpatients, Endocrine Society Clinical Practice Guideline, 2016, DOI: 10.1210/jc.2016-2534

TODO: consider adding scripts/calc.py for the endo-rtcgm-suggest-short-term-intermittent-t2dm calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する